Clinical Trials Directory

Trials / Sponsors / Amneal Pharmaceuticals, LLC

Amneal Pharmaceuticals, LLC

Industry · 12 registered clinical trials2 currently recruiting.

StatusTrialPhaseStarted
CompletedSAD Study to Evaluate Safety, Tolerability, and Pharmacokinetic Profile of AMN1126 in Healthy Post-Menopausal
Healthy Postmenopausal Women
Phase 12024-06-03
RecruitingA Randomized, Double-blind, Parallel-group, Two-arm, Multiple Dose, Multicenter, Bioequivalence Study With Cli
Open-angle Glaucoma, Ocular Hypertension
Phase 12024-04-01
RecruitingBioequivalence Study With Clinical Endpoint Comparing Bimatoprost Ophthalmic Solution 0.01% and LUMIGAN® in th
Glaucoma, Open-Angle, Ocular Hypertension
Phase 32022-06-29
UnknownBE Study in Patients - Methotrexate Tablets
Psoriasis, Rheumatoid Arthritis
Phase 12016-08-01
CompletedStudy Comparing a Generic Diclofenac Sodium Topical Gel, 1% to Voltaren in the Treatment of Subjects With Oste
Osteoarthritis
Phase 32014-04-01
CompletedBioequivalence Study of Test and Reference Testosterone Topical Gel, 1.62% Metered Pump in Testosterone Defici
Primary Hypogonadism, Hypogonadotropic Hypogonadism
Phase 32014-03-01
CompletedComparative Bioequivalence Study in Adult Patients Suffering From Chronic Myeloid Leukemia & Gastrointestinal
Chronic Myeloid Leukemia, Gastrointestinal Stromal Tumor
Phase 2 / Phase 32014-02-01
CompletedStudy to Compare the Therapeutic Equivalence of Mometasone Furoate Nasal Spray, 50 mcg With Nasonex Nasal Spra
Seasonal Allergic Rhinitis
Phase 32014-01-01
CompletedBioequivalence Fasting Study in Patients
Schizophrenia
Phase 2 / Phase 32013-11-01
CompletedStudy to Evaluate the Safety and Bioequivalence of Estradiol Vaginal Inserts, 10 mcg and Vagifem® 10 mcg and C
Atrophic Vaginitis Due to Menopause
Phase 32012-03-01
CompletedSafety and Efficacy of Phenazopyridine Hydrochloride Tablets, USP 200 mg as an Analgesic for Short-Term Treatm
Uncomplicated Urinary Tract Infections
Phase 32012-02-01
CompletedEvaluate the Safety and Efficacy of Phenazopyridine Hydrochloride Tablets, USP 200 mg vs. Placebo
Pain, Urinary Tract Infections
Phase 32009-12-01